Literature DB >> 16787266

Glial modulation of GABAergic and glutamat ergic neurotransmission.

Arne Schousboe1, Helle S Waagepetersen.   

Abstract

Function of astroglia in the modulation of availability, release and clearance (inactivation) of Glu and GABA within the central nervous system is reviewed. Net synthesis of Glu through Gln synthetase exclusively localized in astrocytes can only occur by a metabolic coupling between neurons and astrocytes. Two (GLAST and GLT-1) of the five Glu transporters cloned preferentially expressed in astrocytes perform the astroglial Glu uptake of very high capacity. Moreover, astrocytes have been shown to mediate Glu release by a mechanism mimicking vesicular release. Biosynthesis of GABA in neurons is brought about by decarboxylation of Glu catalyzed by a pyridoxal phosphate requiring enzyme (GAD) that exists in two isoforms (GAD65 and GAD67) exhibiting different subcellular localization and regulatory properties. Detailed studies of GABA synthesis in GABAergic neurons using (13)C NMR spectroscopy have provided evidence for direct involvement of the tricarboxylic acid cycle. Synaptically released GABA taken up into surrounding astrocytes is converted to either CO(2) or Gln. Two reports on the release of GABA in rat dorsal root ganglia indicated that glial cells may perform GABA release as well. Gln formed from GABA in astrocytes can be transferred to GABAergic neurons and subsequently converted to GABA. Inhibition of either degradation or clearance of GABA has been successfully applied in the development of antiepileptics such as vigabatrin or tiagabine. So far, no specific strategy has been developed aimed at stimulating Glu transport.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787266     DOI: 10.2174/156802606777323719

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  17 in total

1.  X-ray structure of Paramecium bursaria Chlorella virus arginine decarboxylase: insight into the structural basis for substrate specificity.

Authors:  Rahul Shah; Radha Akella; Elizabeth J Goldsmith; Margaret A Phillips
Journal:  Biochemistry       Date:  2007-02-17       Impact factor: 3.162

2.  Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders.

Authors:  David M Cochran; Elif M Sikoglu; Steven M Hodge; Richard A E Edden; Ann Foley; David N Kennedy; Constance M Moore; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

3.  Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.

Authors:  Guanghong Liao; Miou Zhou; Simon Cheung; James Galeano; Nam Nguyen; Michel Baudry; Xiaoning Bi
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

4.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole.

Authors:  M Banasr; G M I Chowdhury; R Terwilliger; S S Newton; R S Duman; K L Behar; G Sanacora
Journal:  Mol Psychiatry       Date:  2008-09-30       Impact factor: 15.992

5.  Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes.

Authors:  Tatjana Perisic; Nicole Zimmermann; Thomas Kirmeier; Maria Asmus; Francesca Tuorto; Manfred Uhr; Florian Holsboer; Theo Rein; Jürgen Zschocke
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

Review 6.  Cell-intrinsic signals that regulate adult neurogenesis in vivo: insights from inducible approaches.

Authors:  Madeleine A Johnson; Jessica L Ables; Amelia J Eisch
Journal:  BMB Rep       Date:  2009-05-31       Impact factor: 4.778

7.  Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.

Authors:  Arne Mørk; Louise M Witten; Jørn Arnt
Journal:  Psychopharmacology (Berl)       Date:  2009-06-09       Impact factor: 4.530

8.  TNP-ATP is Beneficial for Treatment of Neonatal Hypoxia-Induced Hypomyelination and Cognitive Decline.

Authors:  Jie Xiao; Yilong Huang; Xia Li; Longjun Li; Ting Yang; Lixuan Huang; Ling Yang; Hong Jiang; Hongchun Li; Fan Li
Journal:  Neurosci Bull       Date:  2016-01-15       Impact factor: 5.203

9.  Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms.

Authors:  Akiko Okada-Ogawa; Ikuko Suzuki; Barry J Sessle; Chen-Yu Chiang; Michael W Salter; Jonathan O Dostrovsky; Yoshiyuki Tsuboi; Masahiro Kondo; Junichi Kitagawa; Azusa Kobayashi; Noboru Noma; Yoshiki Imamura; Koichi Iwata
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

10.  Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen/glucose deprivation in cortical astrocyte cultures: involvement of A1 and A2A adenosine receptors and PI3K, MEK, and PKC pathways.

Authors:  Tharine Dal-Cim; Gabriela G Poluceno; Débora Lanznaster; Karen A de Oliveira; Claudia B Nedel; Carla I Tasca
Journal:  Purinergic Signal       Date:  2019-09-13       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.